{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 65,
        "end": 72
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 208,
        "end": 244
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 247,
        "end": 253
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 294,
        "end": 304
      }
    },
    {
      "id": "T6",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 169,
        "end": 194
      }
    },
    {
      "id": "T7",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 197,
        "end": 203
      }
    },
    {
      "id": "T8",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 260,
        "end": 291
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "19442155_4",
  "text": "In the present paper , we focused on the most direct biochemical lithium targets at therapeutic concentration , for which some pharmacogenetic finding is present ( i.e. inositol mono phosphatase ( IMPase ) , inositol polyphosphate-1-phosphatase ( IPPase ) and glycogen sinthase kinase 3 beta ( GSK-3 beta ) ) ."
}
